Sign in

or Register now

OsteoporosisConnection.com

    See all of our health sites at www.HealthCentral.com
    Monday, November 30, 2009
    • Font size
    • Bookmark
    • Save
      

    FDA approves new dose of Reclast for osteopenia

    (Reuters) UPDATED 2009-06-04
    The U.S. Food and Drug Administration has approved a new dosage of the osteoporosis drug Reclast. The new dose, which is one injection over two years, is approved to treat osteopenia, or low bone mass. The yearly dose of Reclast is already approved for the prevention of osteoporosis in the United States and Europe.  Read full story >
    See all Osteoporosis News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on OsteoporosisConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist